A paradigm shift within the therapy of persistent lymphocytic leukemia (CLL) has taken place over the previous decade, as therapies have progressed from offering palliative aid to inducing full remission, eradicating minimal illness and bettering survival. The event of Rituxan® (rituximab) and its use in immunochemotherapy regimens has remodeled the therapy of CLL and...
Cardiovascular microphysiological systems (CVMPS) for safety studies – a pharma perspective
The integrative responses of the cardiovascular (CV) system are important for sustaining blood circulation to supply oxygenation, vitamins, and waste elimination for the whole physique. Progress has been made in independently growing easy in vitro fashions of two major elements of the CV system, specifically the center (utilizing induced pluripotent stem-cell derived cardiomyocytes) and...